Tata Consultancy Services Ltd.

BSE: 532540 | NSE: TCS
Large Cap | IT - Software
3223.70
54.40 (1.72%)
< Home < Back

TCS launches new version of Connected Clinical Trials platform

Date: 13-12-2018

Tata Consultancy Services (TCS) has released a new version of the Connected Clinical Trials (CCT) platform at the recently concluded TCS ADD Vantage forum in Paris.

CCT is an innovative software-as-a-service (SaaS) platform that enables life sciences companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process. CCT is part of TCS' Advanced Drug Development (ADD) suite that offers a wide range of cloud based clinical solutions and services, including clinical data management, metadata management, pharmacovigilance, and data analytics and insights.

TCS is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.